Annovis Bio Inc – (ANVS, +N, Oct 14th)
Maria-Luisa Maccecchini (CEO since 2008) bought $497,000 of stock on the 11th of October at $27.61, increasing her stake by 2%. This is her first purchase since a minor subscription for $10,000 at $6 in the January 2020 IPO.
Mark White (Non-Executive since 2016) bought $137,000 also on the 11th of October, increasing his holding by 10%, again his first purchase since a minor subscription at the IPO.
The shares have been extremely volatile since listing, hitting a peak of $132 before falling back materially on a clinical trial failure; they are still well above the original IPO price. Whilst these are small purchases relative to their holding they are notable large purchases.
We are ranking the stock +N.
If you want to have Stock of the Week with insider buying stocks information and analysis in your email, don’t forget to subscribe!
Follow us on LinkedIn and Twitter
Check our Signals Performance and if you want to know more about this Signals Service, please, email us at firstname.lastname@example.org or fill in the Contact Us form here.